Ameriprise’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.51B | Buy |
|
|||||
2025
Q1 | $1.96B | Buy |
|
|||||
2024
Q4 | $1.81B | Buy |
|
|||||
2024
Q3 | $1.04B | Buy |
|
|||||
2024
Q2 | $734M | Sell |
|
|||||
2024
Q1 | $1.07B | Sell |
|
|||||
2023
Q4 | $1.43B | Buy |
|
|||||
2023
Q3 | $1.49B | Sell |
|
|||||
2023
Q2 | $1.71B | Buy |
|
|||||
2023
Q1 | $1.81B | Buy |
|
|||||
2022
Q4 | $1.7B | Sell |
|
|||||
2022
Q3 | $1.76B | Sell |
|
|||||
2022
Q2 | $1.93B | Sell |
|
|||||
2022
Q1 | $1.95B | Sell |
|
|||||
2021
Q4 | $1.73B | Sell |
|
|||||
2021
Q3 | $1.69B | Sell |
|
|||||
2021
Q2 | $2.02B | Sell |
|
|||||
2021
Q1 | $1.91B | Buy |
|
|||||
2020
Q4 | $1.78B | Sell |
|
|||||
2020
Q3 | $1.77B | Sell |
|
|||||
2020
Q2 | $1.85B | Buy |
|
|||||
2020
Q1 | $1.68B | Sell |
|
|||||
2019
Q4 | $2.13B | Buy |
|
|||||
2019
Q3 | $1.59B | Buy |
|
|||||
2019
Q2 | $1.21B | Sell |
|
|||||
2019
Q1 | $1.35B | Buy |
|
|||||
2018
Q4 | $1.39B | Buy |
|
|||||
2018
Q3 | $1.56B | Sell |
|
|||||
2018
Q2 | $1.33B | Buy |
|
|||||
2018
Q1 | $998M | Buy |
|
|||||
2017
Q4 | $780M | Sell |
|
|||||
2017
Q3 | $933M | Sell |
|
|||||
2017
Q2 | $867M | Buy |
|
|||||
2017
Q1 | $846M | Buy |
|
|||||
2016
Q4 | $765M | Sell |
|
|||||
2016
Q3 | $961M | Sell |
|
|||||
2016
Q2 | $1.4B | Sell |
|
|||||
2016
Q1 | $1.4B | Sell |
|
|||||
2015
Q4 | $1.58B | Buy |
|
|||||
2015
Q3 | $1.24B | Buy |
|
|||||
2015
Q2 | $1.26B | Sell |
|
|||||
2015
Q1 | $1.3B | Buy |
|
|||||
2014
Q4 | $1.12B | Sell |
|
|||||
2014
Q3 | $1.01B | Buy |
|
|||||
2014
Q2 | $903M | Buy |
|
|||||
2014
Q1 | $855M | Sell |
|
|||||
2013
Q4 | $987M | Buy |
|
|||||
2013
Q3 | $576M | Sell |
|
|||||
2013
Q2 | $709M | Buy |
|